The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized, double-blind phase III trial of niraparib maintenance treatment in patients with HRD+ advanced ovarian cancer after response to front-line platinum-based chemotherapy.
 
Antonio Gonzalez-Martin
Consulting or Advisory Role - PharmaMar; Roche
Speakers' Bureau - AstraZeneca; PharmaMar; Roche
 
Floor Jennishens Backes
Research Funding - Eisai
 
Klaus H. Baumann
No Relationships to Disclose
 
Dana Meredith Chase
Speakers' Bureau - Roche
 
Mathias Konrad Fehr
Stock and Other Ownership Interests - Roche
Travel, Accommodations, Expenses - PharmaMar
 
Robert L. Coleman
Honoraria - NCCN
Consulting or Advisory Role - Clovis Oncology; DOD-CDRMP; Esperance Pharmaceuticals; Genentech/Roche; NCCN
Research Funding - Amgen; Array BioPharma; AstraZeneca/MedImmune; Clovis Oncology; Esperance Pharmaceuticals; Johnson & Johnson; Merrimack; OncoMed
Travel, Accommodations, Expenses - Amgen; Array BioPharma; AstraZeneca/MedImmune; Bayer; Clovis Oncology; Gradalis; Merck; Merrimack; Millennium
 
Gilles Freyer
No Relationships to Disclose
 
Paul DiSilvestro
Consulting or Advisory Role - Genentech/Roche
Research Funding - Genentech/Roche; Janssen Oncology; Tesaro
 
Ofer Lavie
No Relationships to Disclose
 
Thomas J. Herzog
Consulting or Advisory Role - AstraZeneca; Caris Life Sciences; Clovis Oncology; Johnson & Johnson; Roche/Genentech
 
Domenica Lorusso
Consulting or Advisory Role - AstraZeneca; PharmaMar; Roche
Research Funding - PharmaMar
Travel, Accommodations, Expenses - PharmaMar; Roche
 
Kathleen N. Moore
Consulting or Advisory Role - Advaxis; Amgen (Inst); AstraZeneca (Inst); Clovis Oncology (Inst); Genentech/Roche (Inst); Immunogen (Inst); Merrimack
 
Mansoor Raza Mirza
No Relationships to Disclose
 
Roisin Eilish O'Cearbhaill
No Relationships to Disclose
 
Ignace Vergote
No Relationships to Disclose
 
Bhavana Pothuri
No Relationships to Disclose
 
John Balser
No Relationships to Disclose
 
Shefali Agarwal
Employment - Tesaro
Stock and Other Ownership Interests - Tesaro
 
Bradley J. Monk
Consulting or Advisory Role - Advaxis; Amgen; AstraZeneca; Bayer; Cerulean Pharma; Clovis Oncology; GlaxoSmithKline; Gradalis; Immunogen; Insys Therapeutics; Merck; Nucana; Oxigene; Pfizer; Roche/Genentech; Tesaro; Verastem; Vermillion
Speakers' Bureau - AstraZeneca; Janssen; Myriad Genetics; Roche/Genentech
Research Funding - Amgen (Inst); Array BioPharma (Inst); Genentech (Inst); Janssen (Inst); Lilly (Inst); Morphotek (Inst); Novartis (Inst); Tesaro (Inst)